These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 37962749)
1. Heart Failure and Erectile Dysfunction: a Review of the Current Evidence and Clinical Implications. Carella MC; Forleo C; Stanca A; Carulli E; Basile P; Carbonara U; Amati F; Mushtaq S; Baggiano A; Pontone G; Ciccone MM; Guaricci AI Curr Heart Fail Rep; 2023 Dec; 20(6):530-541. PubMed ID: 37962749 [TBL] [Abstract][Full Text] [Related]
2. Erectile dysfunction in heart failure patients: a critical reappraisal. Alberti L; Torlasco C; Lauretta L; Loffi M; Maranta F; Salonia A; Margonato A; Montorsi F; Fragasso G Andrology; 2013 Mar; 1(2):177-91. PubMed ID: 23339018 [TBL] [Abstract][Full Text] [Related]
3. Managing erectile dysfunction in heart failure. Giagulli VA; Moghetti P; Kaufman JM; Guastamacchia E; Iacoviello M; Triggiani V Endocr Metab Immune Disord Drug Targets; 2013 Mar; 13(1):125-34. PubMed ID: 23369145 [TBL] [Abstract][Full Text] [Related]
4. Erectile dysfunction as a complication of heart failure. Baraghoush A; Phan A; Willix RD; Schwarz ER Curr Heart Fail Rep; 2010 Dec; 7(4):194-201. PubMed ID: 20665134 [TBL] [Abstract][Full Text] [Related]
5. Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors. Al-Ameri H; Kloner RA Int J Impot Res; 2009; 21(3):149-57. PubMed ID: 19387454 [TBL] [Abstract][Full Text] [Related]
6. The 2018 Revision to the Process of Care Model for Management of Erectile Dysfunction. Mulhall JP; Giraldi A; Hackett G; Hellstrom WJG; Jannini EA; Rubio-Aurioles E; Trost L; Hassan TA J Sex Med; 2018 Oct; 15(10):1434-1445. PubMed ID: 30057278 [TBL] [Abstract][Full Text] [Related]
7. Update on the Safety of Phosphodiesterase Type 5 Inhibitors for the Treatment of Erectile Dysfunction. Yafi FA; Sharlip ID; Becher EF Sex Med Rev; 2018 Apr; 6(2):242-252. PubMed ID: 28923561 [TBL] [Abstract][Full Text] [Related]
8. New treatment options for erectile dysfunction in patients with diabetes mellitus. Basu A; Ryder RE Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369 [TBL] [Abstract][Full Text] [Related]
9. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496 [TBL] [Abstract][Full Text] [Related]
10. [Sex, erectile dysfunction, and the heart: a growing problem]. Görge G; Flüchter S; Kirstein M; Kunz T Herz; 2003 Jun; 28(4):284-90. PubMed ID: 12825143 [TBL] [Abstract][Full Text] [Related]
11. Effects of heart rate reduction with ivabradine on the international ındex of erectile function (IIEF-5) in patients with heart failure. Mert KU; Dural M; Mert GÖ; Iskenderov K; Özen A Aging Male; 2018 Jun; 21(2):93-98. PubMed ID: 28844168 [TBL] [Abstract][Full Text] [Related]
12. Erectile dysfunction in heart failure: correlation with severity, exercise performance, comorbidities, and heart failure treatment. Apostolo A; Vignati C; Brusoni D; Cattadori G; Contini M; Veglia F; Magrì D; Palermo P; Tedesco C; Doria E; Fiorentini C; Montorsi P; Agostoni P J Sex Med; 2009 Oct; 6(10):2795-805. PubMed ID: 19674255 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal Risk of Developing Cardiovascular Diseases in Patients With Erectile Dysfunction-Which Patients Deserve More Attention? Pozzi E; Capogrosso P; Boeri L; Belladelli F; Baudo A; Schifano N; Abbate C; Dehò F; Montorsi F; Salonia A J Sex Med; 2020 Aug; 17(8):1489-1494. PubMed ID: 32340919 [TBL] [Abstract][Full Text] [Related]
14. Erectile dysfunction and diabetes: a review of the current evidence-based medicine and a synthesis of the main available therapies. Phé V; Rouprêt M Diabetes Metab; 2012 Feb; 38(1):1-13. PubMed ID: 22056307 [TBL] [Abstract][Full Text] [Related]
15. The medical and surgical treatment of erectile dysfunction: a review and update. Karakus S; Burnett AL Can J Urol; 2020 Aug; 27(S3):28-35. PubMed ID: 32876000 [TBL] [Abstract][Full Text] [Related]
16. Effect of Genetic Polymorphism on the Response to PDE5 Inhibitors in Patients With Erectile Dysfunction: A Systematic Review and a Critical Appraisal. Mostafa T; Hassan A; Alghobary MF; Abdelrahman SH Sex Med Rev; 2020 Oct; 8(4):573-585. PubMed ID: 32636154 [TBL] [Abstract][Full Text] [Related]
17. Two Birds with One Stone: Regular Use of PDE5 Inhibitors for Treating Male Patients with Erectile Dysfunction and Cardiovascular Diseases. Cai Z; Zhang J; Li H Cardiovasc Drugs Ther; 2019 Feb; 33(1):119-128. PubMed ID: 30675707 [TBL] [Abstract][Full Text] [Related]
18. [Sexual life quality of spinal cord-injured men receiving pharmacological treatment for erectile dysfunction and their partners]. Sánchez-Ramos A; Galán-Ruano A; Vargas-Baquero E; Mas M Rev Int Androl; 2018; 16(3):95-101. PubMed ID: 30300136 [TBL] [Abstract][Full Text] [Related]
19. Core document on erectile dysfunction: key aspects in the care of a patient with erectile dysfunction. Brotons FB; Campos JC; Gonzalez-Correales R; Martín-Morales A; Moncada I; Pomerol JM Int J Impot Res; 2004 Oct; 16 Suppl 2():S26-39. PubMed ID: 15496854 [TBL] [Abstract][Full Text] [Related]
20. Erectile Dysfunction Treatment Following Radical Cystoprostatectomy: Analysis of a Nationwide Insurance Claims Database. Chappidi MR; Kates M; Sopko NA; Joice GA; Tosoian JJ; Pierorazio PM; Bivalacqua TJ J Sex Med; 2017 Jun; 14(6):810-817. PubMed ID: 28460994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]